2026– date –
-
Quantinuum and SoftBank Joint White Paper Reveals Helios Exceeds Classical Simulation Limits in Quantum Circuit Execution
Quantinuum / SoftBank USA/Japan Overview A new white paper from Quantinuum and SoftBank, "Quantum Computing Frontiers," details how Quantinuum's third-generation quantum computer, Helios, is already executing quantum circuits beyond the ... -
Quantum Computing Market Sees Accelerated Investment in H1 2026, Highlighting PsiQuantum and Diraq
Landbase USA Overview Investment in the quantum computing market significantly accelerated from late 2025 to early 2026, with balanced funding rounds across Europe and North America. PsiQuantum, a leader in photonic quantum computing, is... -
Microsoft Unveils Majorana 2 Topological Quantum Processor, Aiming for Hardware-Level Error Suppression
AZoQuantum USA Overview Microsoft has introduced Majorana 2, a second-generation topological quantum processor designed to intrinsically suppress quantum errors at the hardware level. This approach stands in contrast to existing supercon... -
Breakthroughs in iPSC and 3D Organoids Drive Stem Cell Therapies Towards Clinical Reality and Scalable Manufacturing
Academic/Industry Publication Unknown Overview Stem cell therapies are transitioning rapidly from promise to clinical reality, driven by recent advances in iPSC generation and differentiation. Innovative transcription factor mixes now en... -
Sonoma Biotherapeutics Automates Autologous CAR-Treg Therapy Manufacturing for Rheumatoid Arthritis with Cellares’ Cell Shuttle Platform
Regen Report USA Overview Sonoma Biotherapeutics partnered with Cellares to automate manufacturing of its Phase 1 autologous CAR-Treg therapy (SBT-77-7101) for treatment-resistant rheumatoid arthritis, using Cellares' Cell Shuttle platfo... -
FDA Clears Prime Medicine’s In Vivo Prime Editor for Wilson Disease, Setting Stage for 2027 Data
BioSpace USA Overview Prime Medicine has secured FDA Investigational New Drug (IND) clearance for PM577a, an in vivo Prime Editor designed to correct the H1069Q mutation in Wilson disease. This approval initiates a global Phase 1/2 clini... -
AI and Digital Twin Challenges in GMP Manufacturing: Regulators Demand Audit Trails for Continuously Learning Models
BioPharma APAC Singapore Overview AI and digital twin technologies promise breakthroughs in GMP biomanufacturing, enabling predictive maintenance, real-time release, and high yields. However, regulatory challenges concerning the validati... -
A4BEE Demonstrates Adaptive Digital Twin for Bioprocess Autonomy and Computer Vision for Non-Invasive Foam Management in Bioreactor Control
A4BEE Unknown Overview A4BEE has presented proof-of-concept for an adaptive digital twin aimed at bioprocess autonomy and computer vision for non-invasive foam management in bioreactor control. These innovations seek to bridge the gap be... -
CuraCell Pursues Gentler Preconditioning and Reduced Manufacturing Costs for CC-38 TIL Therapy for Solid Tumors, Enhancing Patient Eligibility and Cost-Effectiveness
Clinical Leader USA Overview CuraCell is focusing on a gentler preconditioning regimen and reduced manufacturing costs for its CC-38 T cell therapy program, which utilizes patient-derived tumor-infiltrating lymphocytes (TILs) for solid t... -
Eli Lilly Acquires Kelonia and Orna Therapeutics as Investment in In Vivo Cell Therapies Surges, Aiming to Reduce Treatment Burden and Manufacturing Costs
DCAT Value Chain Insights USA Overview In vivo cell therapies, where the patient's body becomes the manufacturing site for cells like CAR T cells, are attracting substantial biopharmaceutical investment due to their potential to reduce t...
